AI confidence 51% · refreshes every 15s during session
Investment Snapshot
Why it matters
BOSTON SCIENTIFIC CORP shows stable business momentum based on AlphaOS pipeline evidence, with mixed management execution.
Why it matters: Revenue +12% YoY in Q1 FY2026.
2 signals not yet derived from pipeline evidence
Key signals
What it means for the thesis — synthesis, not a raw event feed.
- Revenue +12% YoY in Q1 FY2026
- REVENUE BEAT
Pipeline evidence · 0d ago
BSX's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on BSX.
Free accounts see more of this; Premium sees all of it.
Latest earnings · Q1 2026
Full BSX earnings analysisReported figures for BOSTON SCIENTIFIC CORP — research only, not investment advice.
- Revenue YoY
- +11.6%
- EPS YoY
- +100.0%
Latest Intelligence
Updated
What happened recently for BOSTON SCIENTIFIC CORP (BSX) — events, not interpretation.
- Event
- Reported Q1 2026 revenue +12% YoY.
- Also
- Last session September 29, 2026 at $43.88.
- Source
- Q1 2026 earnings
Research & analysis only — not investment advice.
Industry & ETF context
Industry blend 53- Primary industry Medical Devices scores 53/100 (Recovery cycle, Neutral momentum).
- Held in 1 ETF(s) — largest weight IHI (4.14%).
Held in ETFsweight · est. sleeve dollars
AlphaOS industries
Investment snapshot
BOSTON SCIENTIFIC CORP
BSX's AI investment thesis
Upgrade to Premium for BSX's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Intelligence layer
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
- →Management tone: neutral
- →Filing signal: Potential insider selling
- →Held in 1 ETF(s) — largest weight IHI (4.14%).
Latest price
$43.88
Market cap
$63.59B
Profitable
Yes
Revenue $5.20B
Net income
$1.34B
FY Sep 18, 2026
Analyst ratings
Loading Wall Street consensus…
Earnings intelligence
Full earnings centerLoading earnings intelligence…
Technical intelligence
Building technical intelligence snapshot — check back shortly.
Loading market context…
Price & volume
0 trading daysNo price history. Sync market data to load charts.
Filing insights
Loading SEC filing intelligence…
Competitive landscape
Recent SEC filings
Filings tabNo filings ingested yet.
BOSTON SCIENTIFIC CORP (BSX)
Investment Snapshot above is the primary AlphaOS analysis for BOSTON SCIENTIFIC CORP — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Key facts
- Sector:
- Healthcare
- Industry:
- Medical Devices
- Market cap:
- $63.59B
- Revenue:
- $5.20B
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected intelligence
Follow BOSTON SCIENTIFIC CORP through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Related & Connected
Related stock research
Connected companies and research pages from the AlphaOS knowledge graph.
- HUMANA INC (HUM)Investment Snapshot & knowledge graph →
- CANADIAN PACIFIC KANSAS CITY LTD/CN (CP)Investment Snapshot & knowledge graph →
- CAMECO CORP (CCJ)Investment Snapshot & knowledge graph →
- UNION PACIFIC CORP (UNP)Investment Snapshot & knowledge graph →
- CARDINAL HEALTH INC (CAH)Investment Snapshot & knowledge graph →
- PACCAR INC (PCAR)Investment Snapshot & knowledge graph →